EurekaMag.com logo
+ Site Statistics
References:
53,214,146
Abstracts:
29,074,682
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Development of a homogeneous assay to measure remnant lipoprotein cholesterol



Development of a homogeneous assay to measure remnant lipoprotein cholesterol



Clinical Chemistry 53(12): 2128-2135



Background: Quantification of triglyceride-rich lipoprotein (TRL) remnants is useful for risk assessment of coronary artery disease and the diagnosis of type III hyperlipoproteinemia. Although an immunoseparation procedure for remnant-like particle cholesterol has been evaluated extensively in recent years, available methods for measuring TRL remnants have not achieved wide use in routine laboratory practice, suggesting a need for a homogeneous assay that can measure TRL remnant cholesterol in serum or plasma without pretreatment.Methods: We screened for suitable surfactants that exhibited favorable selectivity toward the VLDL remnant (VLDLR) fraction, including intermediate-density lipoproteins (IDLs). We investigated the principal characteristics of this assay by gel filtration of lipoproteins and their particle size distribution. We developed a simple assay and evaluated its performance with the Hitachi-7170 analyzer.Results: Polyoxyethylene-polyoxybutylene block copolymer (POE-POB) exhibited favorable selectivity toward VLDLR and IDL fractions. POE-POB removed apolipoprotein (apo) E and apo C-III from IDL particles in the presence of cholesterol esterase (CHER), and the particle size distribution of IDLs became smaller after the reaction. These results revealed that IDL particles are specifically modified in the presence of CHER and POE-POB, making their component cholesterol available for enzymatic assay. Addition of phospholipase D improved the reactivity toward chylomicron remnants (CMRs). We found a high correlation [y = 1.018x- 0.01 mmol/L, r = 0.962 (n = 160)] between the proposed assay and the immunoseparation assay in serum from healthy individuals.Conclusion: The homogeneous assay described in this report can measure TRL remnant cholesterol, including CMRs, VLDLRs, and, IDLs, with high sensitivity and specificity. (C) 2007 American Association for Clinical Chemistry.

(PDF same-day service: $19.90)

Accession: 020840610

Download citation: RISBibTeXText

PMID: 17901111

DOI: 10.1373/clinchem.2007.092296



Related references

Remnant lipoprotein cholesterol level measured by homogeneous assay reflects the quantity of intermediate-density lipoprotein. Rinsho Byori. Japanese Journal of Clinical Pathology 56(5): 367-372, 2008

Increased remnant lipoprotein in patients with coronary artery disease--evaluation utilizing a newly developed remnant assay, remnant lipoproteins cholesterol homogenous assay (RemL-C). Journal of Atherosclerosis and Thrombosis 14(2): 56-64, 2007

Remnant lipoprotein cholesterol homogenous assay (RemL-C) is closely associated with very-low-density lipoprotein remnants: comparison with the immunoseparation assay. Rinsho Byori. Japanese Journal of Clinical Pathology 56(11): 973-979, 2009

Development of a homogeneous assay for measurement of high-density lipoprotein-subclass cholesterol. Clinica Chimica Acta; International Journal of Clinical Chemistry 427(): 86-93, 2015

Highly sensitive cholesterol assay with enzymatic cycling applied to measurement of remnant lipoprotein-cholesterol in serum. Clinical Chemistry 48(5): 737-741, 2002

Interference in a homogeneous assay for low-density lipoprotein cholesterol by lipoprotein X. Clinical Chemistry and Laboratory Medicine 45(5): 667-671, 2007

Evaluation of a rapid remnant lipoprotein cholesterol assay in atherosclerosis. Circulation 94(8 SUPPL ): I121, 1996

Limitations of automated remnant lipoprotein cholesterol assay for diagnostic use. Clinical Chemistry 55(11): 2061-2; Author Reply 2062-3, 2009

Evaluation of a new assay for measurement of remnant lipoprotein cholesterol in patients with coronary artery disease. Clinical Chemistry 43(6 PART 2): S266, 1997

Screening for Type III and other familial hyperlipidemia among Japanese hyperlipidemic subjects by using the remnant lipoprotein cholesterol assay. Clinical Chemistry 49(S6): A163, June, 2003

Evaluation of homogeneous high-density lipoprotein cholesterol assay on a BM/Hitachi 747-200 analyzer. Clinical Chemistry 44(5): 1050-1052, 1998

Homogeneous assay for direct determination of high-density lipoprotein cholesterol evaluated. Clinical Chemistry 42(3): 424-429, 1996

Evaluation of a homogeneous assay for direct determination of high-density lipoprotein cholesterol. Clinical Chemistry 43(6 PART 2): S259, 1997

Comparison of remnant lipoprotein-cholesterol measurements: the immune adsorption method (RLP-C) and the direct assay with detergent (RemL-C). Rinsho Byori. Japanese Journal of Clinical Pathology 57(1): 24-30, 2009

With a novel evaluation method comparison of 2 homogeneous assay kits for high density lipoprotein cholesterol. Clinica Chimica Acta; International Journal of Clinical Chemistry 401(1-2): 110-113, 2009